CN Patent

CN102300558A — 有机化合物的盖伦制剂

Assigned to Novartis AG · Expires 2011-12-28 · 14y expired

What this patent protects

本申请涉及一种用于口服施用的具有片芯和外层包衣的片剂形式的固体单位剂型，其中所述片剂的片芯包含治疗有效量的阿利吉仑或其可药用的盐，外层包衣为具有掩味性能和/或控释功能的膜包衣形式。该片芯片剂优选是多颗粒系统的一部分，特别是小片剂。该固体口服剂型特别适用于儿科应用。

USPTO Abstract

本申请涉及一种用于口服施用的具有片芯和外层包衣的片剂形式的固体单位剂型，其中所述片剂的片芯包含治疗有效量的阿利吉仑或其可药用的盐，外层包衣为具有掩味性能和/或控释功能的膜包衣形式。该片芯片剂优选是多颗粒系统的一部分，特别是小片剂。该固体口服剂型特别适用于儿科应用。

Drugs covered by this patent

Patent Metadata

Patent number
CN102300558A
Jurisdiction
CN
Classification
—
Expires
2011-12-28
Drug substance claim
No
Drug product claim
No
Assignee
Novartis AG
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.